2020 EU-wide Stress Test

Source: RNS
RNS Number : 1477H
Banco Bilbao Vizcaya Argentaria SA
30 July 2021

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby communicates the following:






BBVA has been subject to the 2020 EU-wide Stress Test conducted by the European Banking Authority (EBA), in cooperation with the European Central Bank (ECB) and the European Systemic Risk Board (ESRB).


The 2020 EU-wide Stress Test does not contain a pass/fail threshold, instead it is designed to be used as an important source of information for the Supervisory Review and Evaluation Process (SREP) in 2021. The results will assist competent authorities in assessing BBVA's ability to meet the prudential requirements under stressed scenarios based on a common methodology and assumptions.


The adverse stress test scenario was set by the ECB and the ESRB covering a three-year time horizon (2021-2023) and the stress test scenario has been carried out applying a static balance sheet assumption as of December 31st, 2020. Therefore the stress test scenario does not take into account business strategies and management actions implemented after the cut-off date. As such, the sale of BBVA USA (closed on June 1st, 2021) and the sale of BBVA Paraguay (closed on January 22nd, 2021) were not considered by the exercise.


BBVA's results are summarized below:


●    Under the adverse scenario, BBVA's CET1 fully loaded ratio as of December 31st 2023 decreases 3.03 percentage points to 8.69%.

●    Under the baseline scenario, BBVA's CET1 fully loaded ratio increases 1.28 percentage points to 13% as of December 31st 2023.


Further information is available on the EBA website (www.eba.europa.eu).


Madrid, July 30th 2021


Note: The stress test exercise information is provided in the accompanying disclosure tables based on the common format provided by the EBA. The EU-stress test exercise and its results are not a forecast of BBVA profits.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.